Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 37,500 shares at $62.03 ($2.3M) on 2026-09-15, disclosed to the SEC on 2026-09-17.
Scheduled sale ($2.3M) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.03 | 21,926 | $1.4M | 58.2% |
| 2 | $62.63 | 13,874 | $869K | 37.2% |
| 3 | $63.69 | 1,400 | $89K | 3.8% |
| 4 | $65.31 | 300 | $20K | 0.8% |
| Total | $62.34 avg | 37,500 | $2.3M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |
| TVTX | SELL | 2026-02-19 | $557K | — | Filing → |